Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
World Neurosurg. 2019 Nov;131:e570-e578. doi: 10.1016/j.wneu.2019.07.234. Epub 2019 Aug 7.
Spine surgeons increasingly encounter acute spinal pathologies in patients treated with direct oral anticoagulants (DOACs), but only limited data on the management of these patients are currently available.
We retrospectively analyzed patients who presented to our department with acute spinal pathology during treatment with DOAC and who required urgent surgical therapy. Patient characteristics and treatment modalities were studied, with specific focus on the management of hemostasis and surgical therapy. Furthermore, we analyzed 19 cases of spinal emergencies during DOAC treatment reported in the literature.
A total of 12 patients were identified and included in the present analysis. Patients suffered from acute spinal cord compression caused by spinal tumor manifestation (n = 5), empyema (n = 4), degenerative spinal stenosis (n = 1), hematoma (n = 1), and vertebral body fracture/dislocation (n = 2). All patients underwent emergency surgical treatment. Prohemostatic substances were administered perioperatively in 10 patients (83%) and included administration of prothrombin complex concentrates (83%), tranexamic acid (17%), and transfusion of platelets (8%). A total of 9 patients (75%) showed postoperative improvement of neurologic symptoms, and the in-hospital mortality in this patient cohort was 17%.
Emergency spine surgery is feasible and should be considered in patients on treatment with DOAC. The (low) risk of intraoperative bleeding complications has to be weighed against the risk of permanent disability if surgical decompression is delayed. Administration of prothrombin complex concentrates and tranexamic acid may improve the coagulation before surgery, especially in cases of unavailable specific antidotes.
脊柱外科医生在治疗直接口服抗凝剂(DOAC)的患者时,越来越多地遇到急性脊柱病变,但目前仅有有限的相关处理数据。
我们回顾性分析了在使用 DOAC 治疗期间因急性脊柱病变而就诊并需要紧急手术治疗的患者。研究了患者的特征和治疗方式,特别关注止血和手术治疗的管理。此外,我们分析了文献中报道的 19 例 DOAC 治疗期间发生的脊柱急症病例。
共确定并纳入 12 例患者进行分析。患者因脊柱肿瘤表现(n=5)、脓胸(n=4)、退行性脊柱狭窄(n=1)、血肿(n=1)和椎体骨折/脱位(n=2)导致急性脊髓压迫。所有患者均接受了紧急手术治疗。10 例患者(83%)在围手术期使用了促凝物质,包括使用凝血酶原复合物浓缩物(83%)、氨甲环酸(17%)和血小板输注(8%)。9 例患者(75%)术后神经症状改善,该患者队列的住院死亡率为 17%。
在接受 DOAC 治疗的患者中,可行紧急脊柱手术,且应考虑进行手术。必须权衡术中出血并发症的(低)风险与如果延迟手术减压导致永久性残疾的风险。在手术前使用凝血酶原复合物浓缩物和氨甲环酸可能会改善凝血功能,尤其是在没有特定解毒剂的情况下。